Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Epogen (Epoetin alfa) May 2002

Audience: Pharmacists, distributors, and healthcare professionals

Amgen, with the knowledge of FDA, notified pharmacists and health care providers of counterfeit EPOGEN (epoetin alfa). EPOGEN 40,000 U/mL vials in ten-pack boxes, lot number P002970 expiration date: 7/03 has been found to contain active ingredient that is approximately 20 times lower than would be expected for EPOGEN in 40,000 U/mL vials. Pharmacists and health care providers should carefully examine all vials of EPOGEN before use. A brief description and pictures of the differences between the actual product and the counterfeit are provided.

[May 8, 2002 - Letter - Amgen]

Past MedWatch Alerts:
[Feb 2001 - Letter - Amgen]
[March 2000 - Letter - Amgen]

-
-